KM-401

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameKM-401

Drug Alias Nameadenosine A3 receptor inhibitor (Kainos Medicine)KM-401

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAdenosine A3 receptor antagonists

TargetsAdenosine A3 receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesKainos Medicine Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A